Keith A. Goldan

SNDX

Keith A. Goldan serves as officer: Chief Financial Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$25.0K

Total Sells

6 trades

$269.8K

Net Position

Net Seller

$244.8K

Companies Traded

SNDX

Active Period

Jun 2023 – Feb 2026

7 total trades

Most Recent

Sell SNDX

Feb 10, 2026 · $71.7K

Keith A. Goldan's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

1 · $25.0K

Sells

6 · $269.8K

Total Shares Bought

1,250

Total Shares Sold

14,552

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 10, 2026	Sell	3,410	$21.03	$71.7K	140,429
Feb 9, 2026	Sell	3,410	$21.03	$71.7K	0
Feb 4, 2026	Sell	2,082	$20.62	$42.9K	0
Jul 16, 2025	Sell	1,296	$9.29	$12.0K	0
Feb 12, 2025	Sell	3,777	$15.50	$58.6K	90,746
Jun 17, 2024	Buy	1,250	$20.03	$25.0K	52,623
Jun 14, 2023	Sell	577	$22.31	$12.9K	2,628